#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Study of TCR-Modified T Cell Therapy with ANOC-001, ANOC-002, and ANOC-003 for Adults with Advanced Pancreatic Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Germany The Netherlands Sweden

  • Study of RR001 with Gemcitabine and Paclitaxel for Patients with Locally Advanced Pancreatic Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Study Comparing FOLFOX (Oxaliplatin, Fluorouracil, Calcium Folinate) to Gemcitabine for Patients with Metastatic Pancreatic Cancer Not Suitable for FOLFIRINOX

    Recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study on Ifinatamab Deruxtecan for Patients with Recurrent or Metastatic Solid Tumors

    Recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Ireland Italy The Netherlands +3

  • Study on AZD0901 and Drug Combination for Patients with Advanced Gastric, Gastroesophageal, and Pancreatic Cancers Expressing Claudin 18.2

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland Spain

  • Study on PBP1510 and Gemcitabine for Patients with Advanced Pancreatic Cancer After Previous Chemotherapy

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Study on the Effectiveness and Safety of Autogene Cevumeran, Atezolizumab, and mFOLFIRINOX in Patients with Resected Pancreatic Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Belgium France Germany The Netherlands Spain Sweden

  • Study on the Safety and Effectiveness of GTAEXS617 for Patients with Advanced Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Drugs:
    Belgium

  • Study on Preoperative Treatment with mFOLFIRINOX or Gemcitabine-Paclitaxel for Patients with Borderline Resectable Pancreatic Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium

  • Study of DS-3939a for Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Spain